.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Balancing Efficacy and Quality of Life in Refractory CRC

EP. 1: Treatment Goals in Refractory mCRC

February 17th 2018

EP. 2: Treatment Options in Refractory mCRC

February 17th 2018

EP. 3: The Regorafenib Dose Optimization Study

February 17th 2018

EP. 4: Clinical Implications of the ReDOS Findings

February 17th 2018

EP. 5: Proactive Side Effect Management With Regorafenib

February 17th 2018

EP. 6: Management of Side Effects With TAS-102

February 17th 2018

EP. 7: Sequencing of Therapy in Refractory mCRC

February 17th 2018

EP. 8: Reverce Study: Outcomes and Impact

February 17th 2018

EP. 9: Biomarkers and Novel Approaches in CRC

February 17th 2018